Video Experimental Relacionado

Updated: Jan 7, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Terapia basada en inavolisib para el cáncer de mama masculino avanzado mutado por PIK3CA: un análisis de

Xiaoting Huang^1,2, Shen Lin^1,2, Rongfang Lin^1,2

¹Department of Pharmacy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, People's Republic of China.

Breast cancer (Dove Medical Press)

|January 2, 2026

Resumen

No abstract available in PubMed .

Palabras clave:

PIK3CA-mutado rentabilidad Involucrabilidad cáncer de mama masculino

Más Videos Relacionados

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

Videos de Conceptos Relacionados

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...